Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients (original ) (raw )Cannabis as a substitute for prescription drugs – a cross-sectional study
Michelle Sexton
Journal of Pain Research, 2017
View PDFchevron_right
JPR 134330 cannabis as a substitute for prescription drugs 050217
Jamie Corroon , Michelle Sexton
View PDFchevron_right
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients
Amanda Reiman
Addiction research & theory, 2012
View PDFchevron_right
Opioid Use in Medical Cannabis Authorization Adult Patients from 2013-2018: Alberta, Canada
Lawrence Richer
2021
View PDFchevron_right
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors
Rielle Capler
Drug and alcohol review, 2015
View PDFchevron_right
Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada
Launette M . Rieb
Substance Abuse Treatment, Prevention, and Policy, 2021
View PDFchevron_right
Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use
Rielle Capler
International Journal of Drug Policy, 2013
View PDFchevron_right
Gaps in Evidence for the Use of Medically Authorized Cannabis: Ontario and Alberta, Canada
Dean Eurich
2021
View PDFchevron_right
Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample
Birgitte Thylstrup
Harm Reduction Journal, 2021
View PDFchevron_right
Is Cannabis being used as a substitute for non‐medical opioids by adults with problem substance use in the United States? A within‐person analysis
Malki Stohl
Addiction, 2020
View PDFchevron_right
A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy
John Finnell , Laurie Mischley , Carrie Cuttler , Michelle Sexton
View PDFchevron_right
Reasonable access: important characteristics and perceived quality of legal and illegal sources of cannabis for medical purposes in Canada
Jane Buxton
Journal of cannabis research, 2023
View PDFchevron_right
Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada
Yiu Chak Chung
Psychopharmacology, 2022
View PDFchevron_right
The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario, Canada
David Marsh
PloS one, 2017
View PDFchevron_right
Medical Cannabis Patients: Patient Profiles and Health Care Utilization Patterns
Amanda Reiman
Complementary Health Practice Review, 2007
View PDFchevron_right
Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report
Perry Solomon
Cannabis and Cannabinoid Research, 2017
View PDFchevron_right
Surveying Canadian Pain Physicians’ Attitudes and Beliefs Regarding Medical Cannabis for Chronic Noncancer Pain: A Qualitative Study
Jason Busse
Journal of Pain Research
View PDFchevron_right
Who Are Medical Marijuana Patients? Population Characteristics from Nine California Assessment Clinics
Helen Nunberg
Journal of Psychoactive Drugs, 2011
View PDFchevron_right
Medical cannabis use in the Australian community following introduction of legal access: The 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)
Iain McGregor
Research Square (Research Square), 2020
View PDFchevron_right
Societal issues and policy implications related to the use of cannabinoids, cannabis, and cannabis-based medicines for pain management
Joletta Belton
Pain, 2020
View PDFchevron_right
Chronic Pain Patients' Perspectives of Medical Cannabis
Monica Beals
Pain, 2017
View PDFchevron_right
Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis
Cerina Lee
BMC Public Health, 2020
View PDFchevron_right
Barriers to access for Canadians who use cannabis for therapeutic purposes
Rielle Capler
International Journal of Drug Policy, 2014
View PDFchevron_right
Concerns, beliefs and attitudes of pharmacists and pharmacy students on cannabis use in Canada
Dr Piotr Merks
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
View PDFchevron_right
Association of US Medical Marijuana Laws With Nonmedical Prescription Opioid Use and Prescription Opioid Use Disorder
Silvia S Martins
JAMA Network Open, 2019
View PDFchevron_right
Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain
Shaul Lev-ran
Pain Medicine, 2016
View PDFchevron_right
Cannabis use in Canada: The need for a'public health'approach
Wayne Hall
2009
View PDFchevron_right
Medical cannabis: time for clear thinking
David Penington
The Medical Journal of Australia, 2015
View PDFchevron_right
The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives
Betty Chaar
PLOS ONE, 2016
View PDFchevron_right
Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey
Michelle Sexton
BMC Family Practice
View PDFchevron_right
Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use
anuj shah
Journal of General Internal Medicine, 2019
View PDFchevron_right